GlucoTrack, Inc. - Common Stock GCTK 深 滬
已收盤 09-26 16:00:00 美东时间
6.71
+0.590
+9.64%
華盛通- 最 高6.87
- 今 開6.07
- 成交量 14.57万股
- 最 低 6.07
- 昨 收 6.12
- 總市值 603.50万
- 52周最高 2928.00
- 市盈率 靜 --
- 換手率 16.20%
- 52周最低 4.22
- 委 比 -64.03%
- 總股本 89.94万
- 歷史最高 29100.00
- 量 比 0.82
- 振 幅 13.07%
- 歷史最低 6.07
- 每 手 1
- 風險率 0.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Check-Cap (NASDAQ:CHEK) stock increased by 353.1% to $3.38 during Mond...
09-15 20:10
GlucoTrack Secures $3.6M Convertible Promissory Note
GlucoTrack ( ($GCTK) ) just unveiled an announcement. On September 12, 2025, Gl...
09-13 05:49
美股异动 | 出售最高2000万美元普通股 GlucoTrack(GCTK.US)飙升超123%
周五，GlucoTrack(GCTK.US)飙升超123%，报10.91美元。
09-12 23:29
Market-Moving News for September 12th
SMCI: 6% | Supermicro Launches Global Delivery Of NVIDIA Blackwell Ultra AI Systems For Scalable, Turnkey Deployment GCTK: 190% | GlucoTrack Enters Purchase Agreement With Sixth Borough Capital; Sixth
09-12 19:23
GlucoTrack Secures $20 Million Investment Agreement
The latest update is out from GlucoTrack ( ($GCTK) ). On September 11, 2025, Gl...
09-12 05:18
Glucotrack to Participate in the Q3 Virtual Investor Summit
Glucotrack, Inc. announced that its CEO, Paul V. Goode, PhD, will present at the Q3 Virtual Investor Summit on September 16, 2025, at 1:30PM ET. The presentation will focus on the company's long-term implantable continuous blood glucose monitoring system (CBGM) for people with diabetes. Glucotrack's CBGM is designed for 3-year sensor longevity with minimal calibration and no on-body wearable component. The system is currently limited to investiga...
09-11 12:00
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket
Shares of Carisma Therapeutics, Inc. (NASDAQ:CARM) rose sharply in pre-market t...
09-02 17:28
Glucotrack GAAP EPS of -$9.62
Glucotrack press release (NASDAQ:GCTK): Q2 GAAP EPS of -$9.62. Cash and cash equivalents as of June 30, 2025, were $9.6 million, compared with $5.6 million in cash and cash equivalents as of December ...
08-15 18:19
GlucoTrack Q2 EPS $(9.62) Up From $(984.00) YoY
GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(9.62) per share. This is a 99.02 percent increase over losses of $(984.00) per share from the same period last year.
08-15 04:47
